| Dr Austin Douglas Langel, DNP, CRNA | |
|
1525 W 5th St, Storm Lake, IA 50588 | |
| (712) 732-4030 | |
| Not Available |
| Full Name | Dr Austin Douglas Langel |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 6 Years |
| Location | 1525 W 5th St, Storm Lake, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457713828 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | D131224 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Loring Hospital | Sac city, IA | Hospital |
| Buena Vista Regional Medical Center | Storm lake, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Iowa Anesthesia Associates | 3274424932 | 11 |
| Buena Vista Regional Medical Center | 3476464421 | 13 |
News Archive
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies "Biosimilars" for the Treatment of Cancer.
Genentech and OSI Pharmaceuticals have announced that U.S. regulators have approved their lung cancer drug Tarceva for the treatment of pancreatic cancer.
Beyond plate size and calorie count, the war against obesity may have a new leader - the dinner table. Families that eat together without the television on and stay seated until everyone's finished have children with lower weights and body mass index (BMI), reports a Cornell behavioral economist in the October issue of Obesity.
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of living zebrafish embryos.
Research led by David Hess of the Robarts Research Institute at The University of Western Ontario has identified how to use selected stem cells from bone marrow to grow new blood vessels to treat diseases such as peripheral artery disease.
› Verified 2 days ago
| Entity Name | Iowa Specialty Hospital- Clarion |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396760153 PECOS PAC ID: 3375451347 Enrollment ID: O20031120000622 |
News Archive
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies "Biosimilars" for the Treatment of Cancer.
Genentech and OSI Pharmaceuticals have announced that U.S. regulators have approved their lung cancer drug Tarceva for the treatment of pancreatic cancer.
Beyond plate size and calorie count, the war against obesity may have a new leader - the dinner table. Families that eat together without the television on and stay seated until everyone's finished have children with lower weights and body mass index (BMI), reports a Cornell behavioral economist in the October issue of Obesity.
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of living zebrafish embryos.
Research led by David Hess of the Robarts Research Institute at The University of Western Ontario has identified how to use selected stem cells from bone marrow to grow new blood vessels to treat diseases such as peripheral artery disease.
› Verified 2 days ago
| Entity Name | Trinity Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073594156 PECOS PAC ID: 7315858529 Enrollment ID: O20031204000921 |
News Archive
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies "Biosimilars" for the Treatment of Cancer.
Genentech and OSI Pharmaceuticals have announced that U.S. regulators have approved their lung cancer drug Tarceva for the treatment of pancreatic cancer.
Beyond plate size and calorie count, the war against obesity may have a new leader - the dinner table. Families that eat together without the television on and stay seated until everyone's finished have children with lower weights and body mass index (BMI), reports a Cornell behavioral economist in the October issue of Obesity.
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of living zebrafish embryos.
Research led by David Hess of the Robarts Research Institute at The University of Western Ontario has identified how to use selected stem cells from bone marrow to grow new blood vessels to treat diseases such as peripheral artery disease.
› Verified 2 days ago
| Entity Name | Lakes Regional Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336291160 PECOS PAC ID: 0941118442 Enrollment ID: O20031223000386 |
News Archive
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies "Biosimilars" for the Treatment of Cancer.
Genentech and OSI Pharmaceuticals have announced that U.S. regulators have approved their lung cancer drug Tarceva for the treatment of pancreatic cancer.
Beyond plate size and calorie count, the war against obesity may have a new leader - the dinner table. Families that eat together without the television on and stay seated until everyone's finished have children with lower weights and body mass index (BMI), reports a Cornell behavioral economist in the October issue of Obesity.
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of living zebrafish embryos.
Research led by David Hess of the Robarts Research Institute at The University of Western Ontario has identified how to use selected stem cells from bone marrow to grow new blood vessels to treat diseases such as peripheral artery disease.
› Verified 2 days ago
| Entity Name | Buena Vista Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780755728 PECOS PAC ID: 3476464421 Enrollment ID: O20040109001054 |
News Archive
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies "Biosimilars" for the Treatment of Cancer.
Genentech and OSI Pharmaceuticals have announced that U.S. regulators have approved their lung cancer drug Tarceva for the treatment of pancreatic cancer.
Beyond plate size and calorie count, the war against obesity may have a new leader - the dinner table. Families that eat together without the television on and stay seated until everyone's finished have children with lower weights and body mass index (BMI), reports a Cornell behavioral economist in the October issue of Obesity.
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of living zebrafish embryos.
Research led by David Hess of the Robarts Research Institute at The University of Western Ontario has identified how to use selected stem cells from bone marrow to grow new blood vessels to treat diseases such as peripheral artery disease.
› Verified 2 days ago
| Entity Name | Belmond Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821122623 PECOS PAC ID: 1052201852 Enrollment ID: O20040316001360 |
News Archive
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies "Biosimilars" for the Treatment of Cancer.
Genentech and OSI Pharmaceuticals have announced that U.S. regulators have approved their lung cancer drug Tarceva for the treatment of pancreatic cancer.
Beyond plate size and calorie count, the war against obesity may have a new leader - the dinner table. Families that eat together without the television on and stay seated until everyone's finished have children with lower weights and body mass index (BMI), reports a Cornell behavioral economist in the October issue of Obesity.
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of living zebrafish embryos.
Research led by David Hess of the Robarts Research Institute at The University of Western Ontario has identified how to use selected stem cells from bone marrow to grow new blood vessels to treat diseases such as peripheral artery disease.
› Verified 2 days ago
| Entity Name | Sioux Valley Memorial Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083610190 PECOS PAC ID: 4880501881 Enrollment ID: O20040317001463 |
News Archive
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies "Biosimilars" for the Treatment of Cancer.
Genentech and OSI Pharmaceuticals have announced that U.S. regulators have approved their lung cancer drug Tarceva for the treatment of pancreatic cancer.
Beyond plate size and calorie count, the war against obesity may have a new leader - the dinner table. Families that eat together without the television on and stay seated until everyone's finished have children with lower weights and body mass index (BMI), reports a Cornell behavioral economist in the October issue of Obesity.
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of living zebrafish embryos.
Research led by David Hess of the Robarts Research Institute at The University of Western Ontario has identified how to use selected stem cells from bone marrow to grow new blood vessels to treat diseases such as peripheral artery disease.
› Verified 2 days ago
| Entity Name | Northwest Iowa Anesthesia Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871568493 PECOS PAC ID: 3274424932 Enrollment ID: O20040322001977 |
News Archive
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies "Biosimilars" for the Treatment of Cancer.
Genentech and OSI Pharmaceuticals have announced that U.S. regulators have approved their lung cancer drug Tarceva for the treatment of pancreatic cancer.
Beyond plate size and calorie count, the war against obesity may have a new leader - the dinner table. Families that eat together without the television on and stay seated until everyone's finished have children with lower weights and body mass index (BMI), reports a Cornell behavioral economist in the October issue of Obesity.
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of living zebrafish embryos.
Research led by David Hess of the Robarts Research Institute at The University of Western Ontario has identified how to use selected stem cells from bone marrow to grow new blood vessels to treat diseases such as peripheral artery disease.
› Verified 2 days ago
| Entity Name | Buena Vista Anesthesia Associates Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184603201 PECOS PAC ID: 5890686109 Enrollment ID: O20040324000402 |
News Archive
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies "Biosimilars" for the Treatment of Cancer.
Genentech and OSI Pharmaceuticals have announced that U.S. regulators have approved their lung cancer drug Tarceva for the treatment of pancreatic cancer.
Beyond plate size and calorie count, the war against obesity may have a new leader - the dinner table. Families that eat together without the television on and stay seated until everyone's finished have children with lower weights and body mass index (BMI), reports a Cornell behavioral economist in the October issue of Obesity.
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of living zebrafish embryos.
Research led by David Hess of the Robarts Research Institute at The University of Western Ontario has identified how to use selected stem cells from bone marrow to grow new blood vessels to treat diseases such as peripheral artery disease.
› Verified 2 days ago
| Entity Name | Sioux Valley Memorial Hospital Association |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1689640500 PECOS PAC ID: 4880501881 Enrollment ID: O20070119000412 |
News Archive
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies "Biosimilars" for the Treatment of Cancer.
Genentech and OSI Pharmaceuticals have announced that U.S. regulators have approved their lung cancer drug Tarceva for the treatment of pancreatic cancer.
Beyond plate size and calorie count, the war against obesity may have a new leader - the dinner table. Families that eat together without the television on and stay seated until everyone's finished have children with lower weights and body mass index (BMI), reports a Cornell behavioral economist in the October issue of Obesity.
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of living zebrafish embryos.
Research led by David Hess of the Robarts Research Institute at The University of Western Ontario has identified how to use selected stem cells from bone marrow to grow new blood vessels to treat diseases such as peripheral artery disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Austin Douglas Langel, DNP, CRNA 1525 W 5th St, Storm Lake, IA 50588-3027 Ph: (712) 732-4030 | Dr Austin Douglas Langel, DNP, CRNA 1525 W 5th St, Storm Lake, IA 50588 Ph: (712) 732-4030 |
News Archive
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies "Biosimilars" for the Treatment of Cancer.
Genentech and OSI Pharmaceuticals have announced that U.S. regulators have approved their lung cancer drug Tarceva for the treatment of pancreatic cancer.
Beyond plate size and calorie count, the war against obesity may have a new leader - the dinner table. Families that eat together without the television on and stay seated until everyone's finished have children with lower weights and body mass index (BMI), reports a Cornell behavioral economist in the October issue of Obesity.
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of living zebrafish embryos.
Research led by David Hess of the Robarts Research Institute at The University of Western Ontario has identified how to use selected stem cells from bone marrow to grow new blood vessels to treat diseases such as peripheral artery disease.
› Verified 2 days ago
Briana L Foulk, DNP, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1525 W 5th St Ofc 1, Storm Lake, IA 50588 Phone: 308-430-5025 Fax: 712-749-5114 | |
Angela Christine Boll, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1525 W 5th St, Storm Lake, IA 50588 Phone: 573-686-5550 | |
Mrs. Stephanie Maxine Krauth, CRNA ARNP Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1525 West 5th St, Storm Lake, IA 50588 Phone: 712-732-4030 Fax: 712-749-5114 | |
Mr. Douglas Duane Krauth, CRNA ARNP Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1525 West 5th St, Storm Lake, IA 50588 Phone: 712-730-0127 Fax: 712-730-0127 | |
Monica L Firme, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1525 W 5th St, Storm Lake, IA 50588 Phone: 712-732-4455 |